A novel, first-in-its-kind, aptamer-based LYTACs to address the unmet clinical need of diabetic wounds.

Project Information

APTADEGRAD

Grant agreement ID: 101099063

DOI

10.3030/101099063

EC signature date 25 November 2022

Start date 1 December 2022

End date 30 November 2027

Funded under

• The European Innovation Council (EIC)

Total cost

€ 2 322 037,50

EU contribution

€ 2 321 677,50

Coordinated by

LINCBIOTECH SOCIEDAD LIMITADA
Spain